These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21981280)

  • 1. Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza.
    Kreil TR; Mc Vey JK; Lei LS; Camacho L; Wodal W; Kerschbaum A; Segura E; Vandamme E; Gavit P; Ehrlich HJ; Barrett PN; Baker DA
    Transfusion; 2012 Apr; 52(4):803-9. PubMed ID: 21981280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
    Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice.
    Hohenadl C; Wodal W; Kerschbaum A; Fritz R; Howard MK; Farcet MR; Portsmouth D; McVey JK; Baker DA; Ehrlich HJ; Barrett PN; Kreil TR
    Virol J; 2014 Apr; 11():70. PubMed ID: 24739285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.
    Hung IFN; To KKW; Lee CK; Lee KL; Yan WW; Chan K; Chan WM; Ngai CW; Law KI; Chow FL; Liu R; Lai KY; Lau CCY; Liu SH; Chan KH; Lin CK; Yuen KY
    Chest; 2013 Aug; 144(2):464-473. PubMed ID: 23450336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
    Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
    J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic.
    Khalenkov A; He Y; Reed JL; Kreil TR; McVey J; Norton M; Scott J; Scott DE
    Transfusion; 2018 May; 58(5):1108-1116. PubMed ID: 29446442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection.
    Wong HK; Lee CK; Hung IF; Leung JN; Hong J; Yuen KY; Lin CK
    Transfusion; 2010 Sep; 50(9):1967-71. PubMed ID: 20412524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hark back: passive immunotherapy for influenza and other serious infections.
    Luke TC; Casadevall A; Watowich SJ; Hoffman SL; Beigel JH; Burgess TH
    Crit Care Med; 2010 Apr; 38(4 Suppl):e66-73. PubMed ID: 20154602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.
    Rockman S; Lowther S; Camuglia S; Vandenberg K; Taylor S; Fabri L; Miescher S; Pearse M; Middleton D; Kent SJ; Maher D
    EBioMedicine; 2017 May; 19():119-127. PubMed ID: 28408242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic novel 2009 H1N1 influenza: what have we learned?
    LaRussa P
    Semin Respir Crit Care Med; 2011 Aug; 32(4):393-9. PubMed ID: 21858744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin.
    Planitzer CB; Farcet MR; Schiff RI; Ochs HD; Kreil TR
    J Med Virol; 2011 Feb; 83(2):305-10. PubMed ID: 21181927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1N1 influenza pandemics: comparing the events of 2009 in Mexico with those of 1976 and 1918-1919.
    Franco-Paredes C; Hernandez-Ramos I; Del Rio C; Alexander KT; Tapia-Conyer R; Santos-Preciado JI
    Arch Med Res; 2009 Nov; 40(8):669-72. PubMed ID: 20304254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations.
    Hong DK; Tremoulet AH; Burns JC; Lewis DB
    Pediatr Infect Dis J; 2011 Jan; 30(1):67-9. PubMed ID: 20724956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.